Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 13, 2026 · Filed Nov 16, 2026
Quest Diagnostics's SVP, Corp. Controller & CAO sold $1.43M of Quest Diagnostics shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,434,838
Shares × reported transaction price
22 days after results of Oct 22, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $259.60 on Nov 13, 2026, within 1% of its 52-week high, after an 11% rise over the previous 30 trading days
52-week range $173.49 (Jan 5, 2026) to $259.67 (Nov 9, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $233.33 on Oct 2, 2026. Describes the past only, not a forecast
RSI 69, 20% above its 200-day average, 8% above its 50-day average, 0% below the 52-week high, 20-day volatility 19% a year, against the S&P 500: +11 points over 1 month, +13 points over 3 months, +37 points over 6 months
From the adjusted closes up to Nov 13, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider filing
Traded Nov 13 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Michael J Deppe (SVP, Corp. Controller & CAO) sold ~$1.63M of Quest Diagnostics
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.